Bristol-Myers Squibb Company (BMY) Stock Split, History Data
Working capital analysis
In terms of working capital, Bristol-Myers Squibb Company maintains a healthy position.
The total current assets of the company are valued at $31770000000.
This represents a growth rate of 16.489% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $11464000000, exhibiting a growth rate of 25.660% year-on-year.
The receivables, another significant portion of the current assets, are valued at $15264000000.
The year-on-year growth rate for receivables is 9.521%.
The inventory, which forms a critical part of the assets, is valued at $2662000000.
This represents a healthy year-on-year growth of 13.809%
On the liabilities side, the company's current liabilities total $22262000000.
This reflects a growth rate of 1.699% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
11464.00
9123.00
13979.00
14546.00
12346.00
6911.00
Receavebles
15264.00
13937.00
12516.00
8501.00
7685.00
5965.00
Inventory
2662.00
2339.00
2095.00
2074.00
4293.00
1195.00
Other
1509.00
1596.00
1290.00
1368.00
1983.00
1116.00
Total Current Assets
31770.00
27273.00
33262.00
30192.00
29354.00
8884.00
Acc Payable
3259.00
3040.00
2949.00
2713.00
2445.00
1892.00
Short Term Debt
3281.00
4400.00
5117.00
2504.00
3479.00
1703.00
Other Current Liab
11498.00
13106.00
10109.00
10241.00
7888.00
2064
Current Liabilities
22262.00
21890.00
21868.00
19080.00
18304.00
1703.00
Capital Structure
When examining the capital structure of Bristol-Myers Squibb Company, it is clear that the company manages a robust portfolio.
The value of their total assets clocks in at $99031000000.
When juxtaposed with the previous year, this marks a growth rate of 5.038%, showcasing the company's ability to steadily grow its asset base.
Turning to liabilities, the company has total liabilities amounting to $82483000000.
Compared to the prior year, this reflects a growth rate of 32.195%.
The long-term debt forms a sizable part of these liabilities, coming in at $51050000000.
Over the last year, the long-term debt has grown by 40.063%.
On the asset side, the cash and equivalent reserves are worth $9330000000.
The year-on-year growth of these reserves is 3.724%.
The company's common stock, another important asset, holds a value of $292000000, growing at a rate of 0.000% from the previous year.
Finally, the company's retained earnings stand at $15640000000, marking a growth rate of -41.132% year-over-year.
These earnings represent the profits that Bristol-Myers Squibb Company has chosen to reinvest in the business rather than distribute as dividends.
Total Assets
$99,031.00
Total liabilities
$82,483,000,000.00
Long term debt
$51,050.00
Cash and eqv
$9,330,000,000.00
Goodwill
$21,738.00
Retained earnings
$15,640,000,000.00
Common stock
$0.00
Enterprise Value
$2.43
Historical dividend key summary
Bristol-Myers Squibb Company's dividend per share is $2.34, showing the earnings shared with shareholders per share. It has grown by -51.754% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Years
Q1
Q2
Q3
Q4
Total
2024
0.600
0.500
0.000
0.000
1.100
2023
0.570
0.570
0.570
0.570
2.280
2022
0.540
0.540
0.540
0.540
2.160
2021
0.490
0.490
0.490
0.490
1.960
2020
0.450
0.450
0.450
0.450
1.800
2019
0.410
0.410
0.410
0.410
1.640
2018
0.400
0.400
0.400
0.400
1.600
2017
0.390
0.390
0.390
0.390
1.560
2016
0.380
0.380
0.380
0.380
1.520
2015
0.370
0.370
0.370
0.370
1.480
2014
0.360
0.360
0.360
0.360
1.440
2013
0.350
0.350
0.350
0.350
1.400
2012
0.340
0.340
0.340
0.340
1.360
2011
0.330
0.330
0.330
0.330
1.320
2010
0.320
0.320
0.320
0.320
1.280
2009
0.310
0.310
0.310
0.310
1.240
2008
0.310
0.310
0.310
0.310
1.240
2007
0.280
0.280
0.280
0.280
1.120
2006
0.280
0.280
0.280
0.280
1.120
2005
0.280
0.280
0.280
0.280
1.120
2004
0.280
0.280
0.280
0.280
1.120
2003
0.280
0.280
0.280
0.280
1.120
2002
0.280
0.280
0.280
0.280
1.120
2001
0.262
0.262
0.262
0.275
1.060
2000
0.233
0.233
0.233
0.233
0.933
1999
0.205
0.205
0.206
0.205
0.819
1998
0.186
0.186
0.186
0.186
0.742
1997
0.181
0.181
0.181
0.181
0.723
1996
0.178
0.178
0.178
0.178
0.714
1995
0.176
0.176
0.176
0.176
0.704
1994
0.174
0.174
0.174
0.174
0.695
1993
0.171
0.171
0.171
0.171
0.685
1992
0.164
0.164
0.164
0.164
0.657
1991
0.143
0.143
0.143
0.143
0.571
1990
0.126
0.126
0.126
0.126
0.504
1989
0.119
0.119
0.119
0.119
0.476
1988
0.100
0.100
0.100
0.100
0.400
1987
0.083
0.083
0.083
0.083
0.333
1986
0.000
0.065
0.065
0.000
0.131
1985
0.056
0.056
0.056
0.056
0.224
1984
0.000
0.048
0.000
0.048
0.095
1983
0.031
0.036
0.036
0.036
0.138
1982
0.027
0.031
0.031
0.031
0.121
1981
0.000
0.024
0.027
0.027
0.079
1980
0.024
0.024
0.000
0.024
0.071
1979
0.000
0.021
0.000
0.021
0.043
1978
0.018
0.018
0.000
0.018
0.054
1977
0.016
0.016
0.000
0.016
0.049
1976
0.013
0.013
0.013
0.013
0.054
1975
0.012
0.012
0.012
0.013
0.049
1974
0.011
0.011
0.011
0.011
0.045
1973
0.009
0.010
0.010
0.010
0.038
1972
0.000
0.000
0.009
0.009
0.018
Net earnings per share (EPS)
Bristol-Myers Squibb Company has an EPS of $-5.89, which signifies the profit allocated per share of common stock. With a growth rate of -251.804% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Years
Q1
Q2
Q3
Q4
Total
2024
-5.89
-
-
-
-5.89
2023
1.08
0.99
0.94
0.87
3.88
2022
0.6
0.67
0.75
0.96
2.98
2021
0.9
0.47
0.7
1.1
3.17
2020
-0.34
-0.0376
0.83
-4.45
-4.00
2019
1.05
0.88
0.83
-0.55
2.21
2018
0.91
0.23
1.16
0.73
3.03
2017
0.95
0.56
0.52
-1.42
0.61
2016
0.72
0.7
0.72
0.53
2.67
2015
0.71
-0.08
0.42
-0.0837
0.97
2014
0.57
0.2
0.43
0.0078
1.21
2013
0.37
0.33
0.42
0.44
1.56
2012
0.65
0.38
-0.43
0.56
1.16
2011
0.58
0.53
0.57
0.5
2.18
2010
0.43
0.54
0.55
0.28
1.80
2009
0.32
0.66
0.49
4.1
5.57
2008
0.33
0.39
1.3
0.63
2.65
2007
0.35
0.36
0.43
-0.045
1.10
2006
0.36
0.34
0.17
-0.0683
0.80
2005
0.27
0.51
0.49
0.26
1.53
2004
0.5
0.27
0.39
0.0715
1.23
2003
0.39
0.45
0.46
0.3
1.60
2002
0.3
0.23
0.18
0.17
0.88
2001
0.69
0.62
0.64
0.76
2.71
2000
0.62
0.55
0.63
0.6
2.40
1999
0.54
0.48
0.55
0.53
2.10
1998
0.47
0.42
0.49
0.21
1.59
1997
0.41
0.37
0.43
0.4
1.61
1996
0.36
0.33
0.38
0.35
1.42
1995
0.32
0.3
0.34
-0.0706
0.89
1994
0.28
0.27
0.31
0.0481
0.91
1993
0.28
0.26
0.3
0.12
0.96
1992
0.27
0.24
0.29
0.17
0.97
1991
0.24
0.24
0.27
0.24
0.99
1990
0.2
0.2
0.24
0.21
0.85
1989
0.17
0.17
0.2
-0.17
0.37
1988
0.15
0.15
0.17
0.14
0.61
1987
0.13
0.13
0.13
0.13
0.52
Brief information
Bristol-Myers Squibb Company (BMY) stock split history
Understanding the historical stock splits of Bristol-Myers Squibb Company (BMY) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on August 07, 2001 with a ratio of 1000000:951777. Throughout its history, the company has undergone 6 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
